Bangladesh received another one million doses of Oxford-AstraZeneca vaccine doses from the United Kingdom (UK).
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab.
Australia on Tuesday said that it had not yet received more than 3 million doses of previously promised AstraZeneca COVID-19 vaccine doses amid export curbs by the European Union, leaving a major hole in its early nationwide inoculation drive.
German federal and state governments on Tuesday decided that the AstraZeneca COVID-19 vaccine can only be used for people aged 60 and over from Wednesday.
India temporarily suspended all major exports of the AstraZeneca coronavirus made by the Serum Institute of India (SII), the world’s biggest vaccine-maker, to meet domestic demand as infections rise.
AstraZeneca on Sunday said that its COVID-19 vaccine contains no pork-derived ingredients, countering an assertion in Indonesia, the world’s most populous Muslim nation, that the drug violates Islamic law.
British Prime Minister Boris Johnson has received the first dose of the AstraZeneca COVID-19 vaccine on Friday.
British Prime Minister Boris Johnson on Wednesday said that he will take the vaccine developed by the University of Oxford and AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.
Major EU countries including, Germany, France, Italy, and Spain halted the use of AstraZeneca’s COVID-19 vaccine on Monday after several reports of blood clots in Europe, despite the World Health Organization (WHO) insisted that it is safe to use.
The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca coronavirus vaccine on Sunday over concerns about unexpected side effects and they joined the fast-growing list of countries suspending the use of AstraZeneca’s COVID-19 vaccine.
Brazil’s Health Regulatory Agency (Anvisa) on Friday approved the COVID-19 vaccine developed by Oxford University and pharmaceutical firm AstraZeneca, voicing confidence in it even as a raft of countries suspended its use.
The World Health Organization (WHO) on Friday granted the Johnson & Johnson’s COVID-19 vaccine for emergency use.